Viewing Study NCT03690869

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2026-02-20 @ 6:20 PM
Study NCT ID: NCT03690869
Status: TERMINATED
Last Update Posted: 2025-04-08
First Post: 2018-09-17
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma
Sponsor: Regeneron Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed Solid Tumor View
None Refractory Solid Tumor View
None Relapsed Central Nervous System Tumor View
None Refractory Central Nervous System Tumor View
None Diffuse Intrinsic Pontine Glioma View
None High Grade Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Newly Diagnosed View
None Recurrent View
None Refractory View